IruplinALKib (WX-0593) 是一种有效的、选择性的、具有口服活性的ALK和ROS1酪氨酸激酶抑制剂。IruplinALKib (WX-0593) 在伴有 ALK 或 ROS1 重排的晚期 NSCLC 中显示出良好的安全性和有希望的抗肿瘤活性。

Iruplinalkib (WX-0593) is a potent, selective, and orally active inhibitor of ALK and ROS1 tyrosine kinase. Iruplinalkib (WX-0593) shows favorable safety and promising antitumor activity in advanced NSCLC with ALK or ROS1 rearrangement [1].

1854943-32-0

C29H38ClN6O2P

569.08

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years